Your generous support led to the CHEST Foundation awarding more than a half million dollars in grants at CHEST 2016. The inspiring work of 11 individuals was recognized at our awards ceremony this year, and we’re excited to highlight a few of their outstanding programs and research in this issue of Donor Spotlight.
“I am very proud to have been awarded a CHEST Foundation grant and pleased that clinical research and real-word evidence are a priority to the foundation,” stated Alice Turner, MBChB, MRCP, PhD. Dr. Turner was awarded the 2016 CHEST Foundation and the Alpha-1 Foundation Clinical Research Grant in Alpha-1 Antitrypsin Deficiency. “This award means that my patients can now see publicly the efforts that are being made to reduce inequities in care and ensure that the best treatments are made available in the UK.”
The award will allow Dr. Turner to compare patients who are being treated in the United States with those who are untreated in the United Kingdom and then analyze the effects on mortality, hospitalization, and quality of life to make inferences about whether or not the treatment should be implemented in the United Kingdom. Currently, the type of treatment used to treat patients with alpha-1 antitrypsin deficiency in the United States is not available in the United Kingdom, and the results of this study will be provided to the National Health Service in England to help overcome the barriers of legalizing the treatment in the United Kingdom.
Sydney Montesi, MD, was awarded the CHEST Foundation Research Grant in Pulmonary Fibrosis for her work on using noninvasive lung imaging to see how contrast agents can be used to measure disease activity and progression.
“As a provider, it can be very difficult when we first meet a patient to know what disease course they will take, but if we had this information, it would help us in determining earlier lung transplant referrals, choosing the best therapies and treatments and ultimately lowering the mortality rate of idiopathic pulmonary fibrosis,” Dr. Montesi said of her research. “Receiving this grant is essential because it will allow us to test our hypothesis that vascular leakage is increased in patients with pulmonary fibrosis, and we will also be able to look more in depth at the comparison of patients with stable disease and those with progressive disease.”
Your support helps advance the work of young investigators all over the globe. Because of your generosity, thousands of researchers and community service volunteers have received more than $10 million in funding.
Beginning in February 2017, the foundation will have more than a half million dollars available in funding to the next generation of lung health champions. Are you and your team ready to respond to the call for action? Learn more about the CHEST Foundation grant application process at chestnet.org/grants.